Evaluation of an implementation of PRODIGY phase two.

摘要: Abstract PRODIGY is a prescribing decision-support tool that encourages evidence-based cost-effective and supports information for patients with patient leaflets. Following two successful pilot phases, the Department of Health has announced plans nation-wide rollout to all general practitioners in UK. This paper describes implementation evaluation PRODIGY Phase Two by AAH Meditel, one five participating GP system vendors. Based on results feedback from One, Meditel made number changes software training Two. The showed Meditel's was significantly better than other vendors (27% use versus 13% use), also its own One 9.3% use). Patient leaflets were issued 5.7% times 2.3% 1.0% One. Detailed log files enabled both phases improvements Two, are recommended any clinical project.